Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure
TUMOR MARKERS AfP
Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas | Annals of Hepatology
AFP Tumor Markers | Liver | Medicine
Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas | Annals of Hepatology
PDF) Evaluation of Tumor Markers In Asthma Patients | Abdurrahman Coskun - Academia.edu
AFP Tumor Markers | Liver | Medicine
Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer | Insight Medical Publishing
Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas - ScienceDirect
Comparison of AFP levels at baseline and at 4–8 weeks following... | Download Table
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma. - Abstract - Europe PMC
JCM | Free Full-Text | Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal? | HTML
Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review - ScienceDirect
Early α-fetoprotein response predicts survival in patients with | JHC
Alpha-Fetoprotein in Serum and Tumor Tissues in Dogs with Hepatocellular Carcinoma
Tumor Marker - an overview | ScienceDirect Topics
Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer | Insight Medical Publishing
Cancers | Free Full-Text | Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment | HTML
Tumor Marker - an overview | ScienceDirect Topics
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study | British Journal of Cancer
PDF) AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
Early α-fetoprotein response predicts survival in patients with | JHC
PDF) AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes. - Abstract - Europe PMC
Alpha-fetoprotein (AFP) levels pre-and post-treatment (at 12 weeks) in... | Download Scientific Diagram
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian p
Mean and median values of AFP in the HCC and cirrhosis groups | Download Table
Improving the Detection of Hepatocellular Carcinoma using serum AFP expression in combination with GPC3 and micro-RNA miR-122 expression
